Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma

Ulrike Goelden1, Susanne Pfoertner, Wiebke Hansen

  • 1Department of Cell Biology and Immunology, German Research Centre for Biotechnology, Braunschweig, Germany.

Urologia Internationalis
|October 11, 2005
PubMed
Abstract

Insights

Retinoic acid (RA) shows promise in cancer treatment, but its effectiveness in renal cell carcinoma (RCC) is limited. This study found CRABP-II is downregulated in RCC tumors, and its overexpression did not significantly alter RA

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Retinoic acid (RA) derivatives have demonstrated antiproliferative and tumor-suppressive properties, utilized in treating various cancers.
  • The efficacy of RA in metastatic renal cell carcinoma (RCC) has not met initial expectations, necessitating further investigation into its mechanisms.
  • The precise roles of RA action and cellular retinoic acid-binding proteins (CRABP) in RCC remain unclear.

Purpose of the Study:

  • To investigate the expression of cellular retinoic acid-binding protein II (CRABP-II) in renal cell carcinoma (RCC).
  • To evaluate the potential influence of CRABP-II on the response to retinoic acid (RA) in RCC.
  • To explore the relationship between CRABP-II expression levels and RA-induced antiproliferative effects in RCC cells.

Main Methods:

  • Real-time RT-PCR was employed to assess CRABP-II expression in 12 RCC samples and adjacent normal kidney tissues.
  • CRABP-II was cloned and overexpressed in the CAKI-2 RCC cell line.
  • Antiproliferative effects of all-trans RA (ATRA) and 9-cis RA were evaluated in CRABP-II (un)transfected CAKI-2 cells using 3H-thymidine-proliferation assays.

Main Results:

  • CRABP-II expression was found to be downregulated in primary RCC tumor samples compared to corresponding normal kidney tissue (median tumor/kidney ratios of 0.16 and 0.12).
  • Overexpression of CRABP-II in CAKI-2 RCC cells did not lead to a significant change in sensitivity to RA.
  • CRABP-II overexpressing cells appeared less sensitive to RA stimulation than cells with naturally low CRABP-II levels.

Conclusions:

  • CRABP-II expression is downregulated in primary RCC tumors relative to normal kidney tissue.
  • Overexpression of CRABP-II in RCC cells did not significantly impact RA-mediated antiproliferative effects.
  • Further research is required to elucidate the exact function of CRABP-II and its downregulation in RCC, including its interactions within the RA signaling pathway.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...